SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-109953
Filing Date
2018-04-06
Accepted
2018-04-06 16:03:56
Documents
5
Period of Report
2018-05-21
Effectiveness Date
2018-04-06

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d488872ddef14a.htm DEF 14A 428108
2 GRAPHIC g48887211.jpg GRAPHIC 76412
3 GRAPHIC g4888722.jpg GRAPHIC 92543
4 GRAPHIC g488872g62r17.jpg GRAPHIC 30086
5 GRAPHIC g488872g95j55.jpg GRAPHIC 8747
  Complete submission text file 0001193125-18-109953.txt   715483
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35420 | Film No.: 18743223
SIC: 2834 Pharmaceutical Preparations